Skip to content

Medical-device intelligence

JWY: Manual Antimicrobial Susceptibility Test Systems

FDA product code JWY: Manual Antimicrobial Susceptibility Test Systems. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
JWY
FDA device name
Manual Antimicrobial Susceptibility Test Systems
Device class
2
Regulation number
866.1640
Medical specialty
Microbiology
Review panel
MI

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

441 clearance records and 78 recall records in the covered releases, across 52 source company names and 1 product codes. Dated history runs from Feb 10, 1981 to Apr 21, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202510
November 202500
December 202500
January 202600
February 202600
March 202600
April 202620
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
JWY · Manual Antimicrobial Susceptibility Test Systems44178

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

519 matching records
Device / recordCompany in FDA recordSourceSource date
ETEST CLINICAL ETEST VANCOMYCIN VA M100 US, CATALOG 423788Z-0860-2023 · JWYBiomerieux IncRecallJan 4, 2023FDA classification date
Thermo SCIENTIFIC Sensititre Plate, GN4F, Gram Negative IVD ASTZ-0327-2023 · JWYRemel IncRecallDec 8, 2022FDA classification date
Thermo SCIENTIFIC, Sensititre GN6F, Gram Negative IVD ASTZ-0328-2023 · JWYRemel IncRecallDec 8, 2022FDA classification date
Thermo SCIENTIFIC, Sensititre GN7F, Gram Negative IVD ASTZ-0329-2023 · JWYRemel IncRecallDec 8, 2022FDA classification date
Thermo SCIENTIFIC, Sensititre HPB1, Gram Negative IVD ASTZ-0330-2023 · JWYRemel IncRecallDec 8, 2022FDA classification date
Thermo SCIENTIFIC, Sensititre CMC5VGNF, Gram Negative IVD ASTZ-0331-2023 · JWYRemel IncRecallDec 8, 2022FDA classification date
Thermo SCIENTIFIC, Sensititre CMC7AFLF, Gram Negative IVD ASTZ-0332-2023 · JWYRemel IncRecallDec 8, 2022FDA classification date
Thermo SCIENTIFIC, Sensititre MDRGN3F, Gram Negative IVD ASTZ-0333-2023 · JWYRemel IncRecallDec 8, 2022FDA classification date
Thermo SCIENTIFIC, Sensititre STP6F, Gram Negative IVD ASTZ-0334-2023 · JWYRemel IncRecallDec 8, 2022FDA classification date
Thermo SCIENTIFIC, Sensititre STP7F, Gram Negative IVD ASTZ-0335-2023 · JWYRemel IncRecallDec 8, 2022FDA classification date
Thermo Scientific Sensititre Gram Negative Susceptibility Testing Plate, IVD formatZ-0722-2022 · JWYRemel IncRecallMar 4, 2022FDA record creation date
Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Cefiderocol in the dilution range of 0.03-64 ug/mlK203741 · JWYThermo Fisher Scientific510(k)Dec 20, 2021FDA decision date
ETEST Fosfomycin (FO) (0.032-512 µg/mL)K210757 · JWYBiomerieux S.A.510(k)Nov 12, 2021FDA decision date
MTS Piperacillin-tazobactam 0.016/4 - 256/4µg/mLK211672 · JWYLiofilchem s.r.l.510(k)Oct 20, 2021FDA decision date
ETEST IMIPENEM RELEBACTAM. in vitro diagnosticZ-2226-2021 · JWYBiomerieux IncRecallAug 6, 2021FDA record creation date
Sensititre 20-24 hour Haemophilus influenzae /Streptococcus pneumoniae MIC or Breakpoint Susceptibility System with Dtest (containing erythromyci…K202612 · JWYThermo Fisher Scientific510(k)Jul 23, 2021FDA decision date
MicroScan MICroSTREP plus Panels with Tetracycline (0.06-16 µg/mL)K202423 · JWYBeckman Coulter, Inc.510(k)May 18, 2021FDA decision date
ETEST Plazomicin (PLZ) (0.016-256 µg/mL)K200512 · JWYBiomérieux SA510(k)May 7, 2020FDA decision date
MTS Lefamulin 0.016- 256 µg/mLK200308 · JWYLiofilchem S. R. 1.510(k)Apr 6, 2020FDA decision date
MTS Omadacycline 0.002 - 32 ug/mLK200180 · JWYLiofilchem s.r.l.510(k)Mar 20, 2020FDA decision date
Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Cefiderocol in the dilution range of 0.03-64 µg/mlK193538 · JWYThermo Fisher Scientific510(k)Mar 12, 2020FDA decision date
Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae MIC or Breakpoint, Susceptibility System with Lefamulin in the dilution ran…K193024 · JWYThermo Fisher Scientific510(k)Jan 8, 2020FDA decision date
ETEST Delafloxacin (DFX) (0.002-32 µg/mL)K192738 · JWYBiomerieux S.A.510(k)Nov 26, 2019FDA decision date
MicroScan Dried Gram Negative MIC/Combo Panels with Meropenem (Mer) (0.004-32ug/mL)K192355 · JWYBeckman Coulter, Inc.510(k)Nov 14, 2019FDA decision date
Sensititre 18-24 Hour MIC or Breakpoint Susceptibility System with Lefamulin in the dilution range of 0.008-16ug/mlK192729 · JWYThermo Fisher Scientific510(k)Nov 6, 2019FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗